GD
Galaxy Diagnostics, Inc.
SEC filingBiotechnology · Durham, NC
Amount raised$3Msold at filing
Total offering$5.7M$2.7M still open
Investors in the raise45count reported to the SEC
FiledJun 3, 2026first sale May 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Amanda Jefferson ElamDirector
Joel Jefferson KimbroughDirector
Nicole BellExecutive Officer, Director
Edward Jefferson BreitschwerdtDirector
B. Jefferson ClarkExecutive Officer, Director
Richard Jefferson WestDirector
Executive officers, directors and promoters as listed on the Form D.